PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 16, 2026Epileptic Disorders0 citations

Vagus nerve stimulation for drug‐resistant epilepsy and predictors for seizure freedom: A nationwide multicenter cohort study in Mexico

View Full Paper
MCMaría F Castelo-PablosAHAlma M. Huerta‐HurtadoIAImmer Armendáriz‐Betancourt

Key Points

  • To evaluate the effectiveness of vagus nerve stimulation in drug-resistant epilepsy and identify factors predicting seizure freedom.
  • Retrospective multicenter cohort study across 13 epilepsy centers in Mexico.
  • Included patients aged ≥4 years with drug‐resistant epilepsy or epileptic encephalopathy.
  • Measured treatment response as at least 50% seizure reduction and employed logistic regression for analysis.
  • Median monthly seizure frequency decreased by 82.5% at 1 year (from 40 to 7).
  • Seizure freedom achieved by 11.8% of patients.
  • Baseline seizure frequency ≥30/month independently predicted seizure freedom with 97.7% lower odds.

Abstract

Abstract Objective To evaluate clinical outcomes, treatment response and predictors of seizure freedom after vagus nerve stimulation in patients with drug‐resistant epilepsy in a Mexican cohort. Methods We conducted a retrospective multicenter cohort across 13 epilepsy centers in Mexico (2003–2024) including patients aged ≥4 years with drug‐resistant epilepsy or epileptic encephalopathy. Treatment response was defined as at least 50% seizure reduction and Engel outcomes. Logistic regression identified predictors of seizure freedom. Model performance was assessed with receiver operating characteristic analysis, area under the curve, Hosmer–Lemeshow test, and a confusion matrix. Results Ninety‐three patients (51 children, 42 adults) were included. At 1 year, median monthly seizure frequency decreased by 82.5% (40–7; p < .001). The incidence of status epilepticus declined by 92.8%, acute prolonged seizures by 80.9%, the burden of antiseizure medications by 25%, and epilepsy‐related hospitalizations by 100% (all p < .001). Overall, 68.8% achieved ≥50% reduction and 11.8% became seizure‐free. On univariate analysis, comorbidities, multiple seizure types, higher baseline seizure frequency, greater number of antiseizure medications, and magnet use were inversely related to seizure freedom, while normal brain MRI showed a direct relationship. On multivariable analysis, only baseline seizure frequency ≥30/month independently predicted seizure freedom ( p = .047), corresponding to 97.7% lower odds. A predictive model incorporating comorbidities and number of antiseizure medications improved discrimination ( p < .001) with 86.6% sensitivity and 81.8% specificity. Significance Vagus nerve stimulation was associated with substantial seizure frequency reduction, lower morbidity, and less healthcare utilization, with a favorable safety profile. Baseline seizure burden emerged as the key predictor of seizure freedom and may guide patient selection, supporting earlier vagus nerve stimulation consideration in drug‐resistant epilepsy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Castelo-Pablos et al. (2026) studied this question.

synapsesocial.com/papers/699264d1eb1f82dc367a0b96https://doi.org/10.1002/epd2.70202
Ask AI
Helpful
Bookmark
Share
View Full Paper